Clinical Trials Directory

Trials / Completed

CompletedNCT03899779

Face-to-face Versus Online Hypnotherapy for the Treatment of Irritable Bowel Syndrome

Face-to-face Versus Online Hypnotherapy for the Treatment of Irritable Bowel Syndrome, According to a Non-inferiority Design. Three-armed Randomized Controlled Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
282 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
16 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Psychological therapies are effective in reducing irritable bowel syndrome (IBS) symptom severity and increasing quality of life and are recommended for the management of IBS by guidelines. Evidence appears strongest for the efficacy of hypnotherapy as psychological treatment. However, therapist-led interventions are time consuming and relatively costly. Approaches based on e-health are cost saving and appear more attractive to patients as no visits to a therapist are necessary. Therefore, the investigators plan to conduct a multicentre randomised controlled trial to examine whether the effectiveness of online hypnotherapy is non-inferior compared to individual face-to-face hypnotherapy delivered by a therapist, according to current FDA guidelines. Online psychoeducation will be used as control condition. In addition, the investigators hypothesize that treatment with online hypnotherapy is a more cost-effective therapy than face-to-face hypnotherapy in IBS patients.

Conditions

Interventions

TypeNameDescription
OTHERFace-to-face hypnotherapy12 weeks treatment with face-to-face hypnotherapy (6 individual, bi-weekly sessions)
OTHEROnline hypnotherapy12 weeks treatment with online hypnotherapy
OTHEROnline psychoeducation12 weeks treatment with online psychoeducation

Timeline

Start date
2019-07-08
Primary completion
2024-12-29
Completion
2025-06-29
First posted
2019-04-02
Last updated
2025-07-18

Locations

6 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03899779. Inclusion in this directory is not an endorsement.